PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11117526-6	2000	Medroxyprogesterone acetate (MPA) increased the promoter activities ranging from 1.2- to 27-fold in cells cotransfected with hPR-A or hPR-B in eight endometrial specimens.	Medroxyprogesterone Acetate	0-27	S100 calcium binding protein A6	Homo sapiens	125-130	
26243545-7	2016	Incubation of cervical fibroblasts with PR ligands (medroxyprogesterone acetate or Org-2058) downregulated PR-A and PR-B levels.	Medroxyprogesterone Acetate	52-79	S100 calcium binding protein A6	Homo sapiens	107-111	
9271335-0	1997	Calcyclin gene expression modulation by medroxyprogesterone acetate.	Medroxyprogesterone Acetate	40-67	S100 calcium binding protein A6	Homo sapiens	0-9	
9408241-4	1997	Western blot analysis showed that progesterone or medroxyprogesterone acetate increased the two isoforms, PR-A and PR-B, in stromal cells but reduced them in glandular epithelial cells.	Medroxyprogesterone Acetate	50-77	S100 calcium binding protein A6	Homo sapiens	106-110	
9271335-2	1997	This paper illustrates medroxyprogesterone acetate (MPA) inhibition of endogenous calcyclin RNA expression of both estrogen-dependent human mammary carcinoma cells and estrogen-independent hamster fibroblasts.	Medroxyprogesterone Acetate	23-50	S100 calcium binding protein A6	Homo sapiens	82-91